A role for mitochondrial Bak in apoptotic response to anticancer drugs
G Q Wang1, B R Gastman, E Wieckowski
1Department of Pathology, The University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA.
Abstract:
In the present study a clonal Jurkat cell line deficient in expression of Bak was used to analyze the role of Bak in cytochrome c release from mitochondria. The Bak-deficient T leukemic cells were resistant to apoptosis induced by UV, staurosporin, VP-16, bleomycin, or cisplatin. In contrast to wild type Jurkat cells, these Bak-deficient cells did not respond to UV or treatment with these anticancer drugs by membranous phosphatidylserine exposure, DNA breaks, activation of caspases, or release of mitochondrial cytochrome c. The block in the apoptotic cascade was in the mitochondrial mechanism for cytochrome c release because purified mitochondria from Bak-deficient cells failed to release cytochrome c or apoptosis-inducing factor in response to recombinant Bax or truncated Bid. The resistance of Bak-deficient cells to VP-16 was reversed by transduction of the Bak gene into these cells. Also, the cytochrome c releasing capability of the Bak-deficient mitochondria was restored by insertion of recombinant Bak protein into purified mitochondria. Following mitochondrial localization, low dose recombinant Bak restored the mitochondrial release of cytochrome c in response to Bax; at increased doses it induced cytochrome c release itself. The function of Bak is independent of Bid and Bax because recombinant Bak induced cytochrome c release from mitochondria purified from Bax(-/-), Bid(-/-), or Bid(-/-) Bax(-/-) mice. Together, our findings suggest that Bak plays a key role in the apoptotic machinery of cytochrome c release and thus in the chemoresistance of human T leukemic cells.
Insights
Bak protein is crucial for initiating apoptosis by enabling cytochrome c release from mitochondria. Its absence confers chemoresistance in T leukemic cells, highlighting Bak
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Apoptosis, or programmed cell death, is a critical process in multicellular organisms.
- Mitochondria play a central role in the intrinsic apoptotic pathway.
- Cytochrome c release from mitochondria is a key event triggering apoptosis.
Purpose of the Study:
- To investigate the specific role of Bak, a Bcl-2 family protein, in cytochrome c release.
- To determine if Bak deficiency contributes to chemoresistance in human T leukemic cells.
Main Methods:
- Utilized a clonal Jurkat T leukemic cell line engineered to be deficient in Bak expression.
- Assessed apoptosis induction via various stimuli (UV, anticancer drugs) in Bak-deficient vs. wild-type cells.
- Examined mitochondrial function, cytochrome c release, and caspase activation.
- Restored Bak expression and function through gene transduction and recombinant protein addition.
Main Results:
- Bak-deficient cells exhibited resistance to apoptosis induced by multiple stimuli.
- These cells failed to release cytochrome c from mitochondria, indicating a block at the mitochondrial level.
- Restoring Bak expression or adding recombinant Bak protein rescued the apoptotic phenotype and restored cytochrome c release.
- Bak's function in cytochrome c release was independent of Bid and Bax proteins.
Conclusions:
- Bak is essential for the mitochondrial release of cytochrome c, a critical step in apoptosis.
- Bak deficiency confers chemoresistance in human T leukemic cells.
- Targeting Bak may represent a therapeutic strategy to overcome chemoresistance in T leukemias.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Apoptosis
Caspases
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy


